AIM - AIM ImmunoTech Inc.
0.0949
-0.023 -24.025%
Share volume: 2,305,517
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.12
-0.02
-0.19%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-27-2025 | |
| Assets | ||
| Total Assets | 8.608 M | |
| Current Assets | 4.176 M | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 2.276 M | |
| Total Receivables | 0.000 | |
| Current Cash | 1.701 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 108.000 K | |
| Other Assets | 4.324 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 8.608 M | |
| Total liabilities | 9.930 M | |
| Total current liabilities | 9.535 M | |
| Accounts Payable | 6.383 M | |
| Other liabilities | 395.000 K | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 395.000 K | |
| Minority interest | 0.000 | |
| Total Shareholder equity | -1.322 M | |
| Common stock | 425.506 M | |
| Retained earnings | -426.828 M |
